A detailed history of Sierra Summit Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Sierra Summit Advisors LLC holds 2,704 shares of AMGN stock, worth $856,924. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,704
Previous 22,392 87.92%
Holding current value
$856,924
Previous $6.37 Billion 86.73%
% of portfolio
0.21%
Previous 1.73%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $5.17 Million - $6.29 Million
-19,688 Reduced 87.92%
2,704 $845 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $6.02 Million - $7.27 Million
22,392 New
22,392 $6.37 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sierra Summit Advisors LLC Portfolio

Follow Sierra Summit Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Summit Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Summit Advisors LLC with notifications on news.